Your browser doesn't support javascript.
loading
SEOM-GEINO clinical guidelines for grade 2 gliomas (2023).
Vaz-Salgado, María Ángeles; García, Belén Cigarral; Pérez, Isaura Fernández; Munárriz, Beatriz Jiménez; Domarco, Paula Sampedro; González, Ainhoa Hernández; Villar, María Vieito; Caro, Raquel Luque; Delgado, María Luisa Villamayor; Sánchez, Juan Manuel Sepúlveda.
Affiliation
  • Vaz-Salgado MÁ; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (Irycis) CIBERONC, Madrid, Spain. mariaangeles.vaz@salud.madrid.org.
  • García BC; Medical Oncology Department, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
  • Pérez IF; Medical Oncology Department, Hospital Alvaro Cunqueiro-Complejo Hospitalario Universitario de Vigo, Pontevedra, Spain.
  • Munárriz BJ; Medical Oncology Department, HM Universitario Sanchinarro-CIOCC, Madrid, Spain.
  • Domarco PS; Medical Oncology Department, Complexo Hospitalario Universitario de Ourense (CHUO), Orense, Spain.
  • González AH; Medical Oncology Department, Hospital Germans Trias I Pujol(ICO)-Badalona, Instituto Catalán de Oncología, Barcelona, Spain.
  • Villar MV; Medical Oncology Department, Hospital Universitario Vall D'Hebron, Barcelona, Spain.
  • Caro RL; Medical Oncology Department, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria Ibs.Granada, Granada, Spain.
  • Delgado MLV; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Sánchez JMS; Neuro-Oncology Unit, HM Universitario Sanchinarro-CIOCC, Madrid, Spain. sepulvedasanchez@seom.org.
Clin Transl Oncol ; 2024 Apr 25.
Article in En | MEDLINE | ID: mdl-38662171
ABSTRACT
The 2021 World Health Organization (WHO) classification has updated the definition of grade 2 gliomas and the presence of isocitrate dehydrogenase (IDH) mutation has been deemed the cornerstone of diagnosis. Though slow-growing and having a low proliferative index, grade 2 gliomas are incurable by surgery and complementary treatments are vital to improving prognosis. This guideline provides recommendations on the multidisciplinary treatment of grade 2 astrocytomas and oligodendrogliomas based on the best evidence available.
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Transl Oncol Year: 2024 Document type: Article Affiliation country: España Publication country: IT / ITALIA / ITALY / ITÁLIA
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Transl Oncol Year: 2024 Document type: Article Affiliation country: España Publication country: IT / ITALIA / ITALY / ITÁLIA